| COVID-19 Vaccine |
1 |
1 |
| Myocarditis |
0 |
0.99 |
| Cardiomyopathy |
0 |
0.84 |
| COVID-19 |
0 |
0.98 |
| Vaccines |
0 |
0.97 |
| Severe Acute Respiratory Syndrome |
0 |
0.8 |
| Acute Respiratory Distress Syndrome |
0 |
0.75 |
| California |
0 |
0.12 |
| Arrhythmia |
0 |
0.1 |
| Heart Failure (HF) |
0 |
0.1 |
| Health Care Organizations |
0 |
0.09 |
| Cardiogenic Shock |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Immunization |
0 |
0.07 |
| Nail |
0 |
0.07 |
| Atrial Fibrillation |
0 |
0.06 |
| Adolescent Medicine |
0 |
0.05 |
| Shock |
0 |
0.05 |
| Wound Management |
0 |
0.05 |
| Health Care Services |
0 |
0.03 |
| Pain Management |
0 |
0.03 |
| Ventricular Tachycardia |
0 |
0.03 |
| Board Certification |
0 |
0.02 |
| Clinical Research |
0 |
0.02 |
| Fellowship |
0 |
0.02 |
| Geriatrics |
0 |
0.02 |
| Health Care Facilities, Manpower, and Services |
0 |
0.02 |
| Injury |
0 |
0.02 |
| Intensive Care Unit |
0 |
0.02 |
| Left Ventricular Dysfunction |
0 |
0.02 |
| New York |
0 |
0.02 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.02 |
| Tachycardia |
0 |
0.02 |